Your session is about to expire
← Back to Search
Emotion & Attention Training for TBI and PTSD
Study Summary
This trial will test whether a multimodal affect recognition training (MMART), which includes training in both facial and vocal emotion recognition, can improve emotion recognition and attention in Veterans with mTBI and PTSD.
Timeline
Treatment Details
Study Objectives
Outcome measures can provide a clearer picture of what you can expect from a treatment.Trial Design
Find a Location
Who is running the clinical trial?
Media Library
- My hearing is within normal range.I have a long-term illness or a condition affecting my nervous system.I am a veteran diagnosed with mild traumatic brain injury and PTSD.
- Group 1: MMART and attention training
- Group 2: Brain Health Workshop and National Geographic Movies
- Screening: It may take up to 3 Weeks to process to see if you qualify in this trial.
- Treatment: The duration you will receive the treatment varies.
- Follow Ups: You may be asked to continue sharing information regarding the trial for 6 Months after you stop receiving the treatment.
Frequently Asked Questions
Who meets the eligibility requirements for this experiment?
"20 individuals who have post-traumatic stress disorder (PTSD) and between the ages of 25-50 are eligible for this trial. In order to participate, potential candidates must meet certain requirements which are as follows: being a veteran with a diagnosis of mTBI and PTSD based on VA/Department of Defense guidelines, an emotion recognition deficit, attention deficit, corrected vision within normal limits, hearing within normal limits, and finally being fluent in English."
Are we looking for new participants in this research project?
"According to the information available on clinicaltrials.gov, this trial is no longer recruiting patients. This study was originally posted on December 1st, 2022 and was last edited on July 25th, 2022. Although this specific trial is not enrolling new participants, there are 736 other studies that are still looking for subjects."
If an older patient wants to enroll in this research, will they be accepted?
"This clinical trial is enrolling individuals aged 25-50."
What does the FDA have to say about affect recognition training?
"While Phase 2 trials don't have the same level of data supporting efficacy, there is some clinical evidence backing up the safety of multimodal affect recognition training-- so it received a score of 2."
Share this study with friends
Copy Link
Messenger